Disruptions in glucose and amyloid-beta transport in mouse models manifesting metabolic syndrome
Lushan WangiD, Geoffry L. Curran, Chaitanya Chakravarthi GaliiD, Andrew L. Zhou, Paul H. Min, Val J. LoweiD, Karunya K. KandimallaiD
Abstract
Studies in humans and murine models have pointed towards a possible link between metabolic syndrome, which shows insulin resistance and metabolic dysregulation, and Alzheimer's disease (AD) pathology marked by amyloid-beta (A{beta}) accumulation and hypometabolism in the brain. Yet, the underlying biological mechanisms by which metabolic syndrome affects these pathological changes in AD brain remain unknown. We hypothesized that insulin resistance is responsible for alterations in blood-brain barrier (BBB) transport of A{beta} peptides and glucose. This hypothesis was tested by employing radiolabeled ligands (125I-A{beta}40, 125I-A{beta}42, and 18F-FDG) in high-fat diet (HFD)-fed mouse models that manifest metabolic syndrome. Further, we assessed alterations in the expression of various molecular mediators within the brain microcapillaries harvested from both low-fat diet (LFD)-fed and HFD-fed mice. Our findings show that HFD-fed mice developed peripheral insulin resistance and obesity. In addition, HFD-fed mice demonstrated an increase in the influx rate of A{beta} peptides and a reduction in 18F-FDG (a glucose surrogate) influx rate compared to LFD-fed mice. These transport changes are associated with the increase in the BBB endothelial expression of RAGE (receptor to traffic A{beta} from plasma-to-brain) and reduction of GLUT1 (glucose transporter) expression in HFD-fed mice compared to LFD-fed mice. Moreover, disruption in insulin signaling, as indicated by reduced pAKT and pERK expression, was observed in HFD-fed mice. Inhibiting AKT or ERK phosphorylation resulted in similar changes in A{beta} and glucose uptake in polarized BBB endothelial cell monolayers in vitro. These results indicate that high-fat diet induced metabolic syndrome may lead to BBB dysfunction, characterized by increased plasma-to-brain A{beta} trafficking and diminished glucose transport at the BBB, thereby aggravating the expression of AD pathological hallmarks.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amyloid Beta Peptides Inhibit Glucose Transport at the Blood-brain Barrier by Disrupting Insulin-Akt Pathway in Alzheimer's Disease
L. Wang, G. L. Curran, … K. K. Kandimalla·bioRxiv·Nov 21, 2022
- Butyrate regulates the blood-brain barrier transport and intra-endothelial accumulation of Alzheimers disease Amyloid-beta peptides
Vaishnavi Veerareddy, Zengtao Wang, … Karunya K. Kandimalla·Molecular PharmaceuticsPeer-reviewed·May 21, 2026
- Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer knock-in mouse phenotypes
LaShae Nicholson, Si Jie Tang, … Stephen M. Strittmatter·Molecular NeurodegenerationPeer-reviewed·Jun 3, 2026
- ACUTE AMYLOID-B 40 EXPOSURE DISRUPTS METABOLIC INSULIN SIGNALING IN BLOOD-BRAIN BARRIER ENDOTHELIAL CELLS
Douglas B. Nelson, Krishna R. Kalari, Karunya K. Kandimalla·bioRxiv·Nov 21, 2025
- DIET INFLUENCES PERIPHERAL AMYLOID BETA METABOLISM: A ROLE FOR CIRCULATING INSULIN-LIKE GROWTH FACTOR I
Raquel Herrero-Labrador, Ángel Trueba-Sáiz, … I. Torres Aleman·bioRxiv·Jul 9, 2020
- Exenatide reverts the high-fat-diet-induced impairment of BDNF signaling and inflammatory response in an animal model of Alzheimer’s disease
Manuela Bomba, Alberto Granzotto, … Stefano Luca Sensi·Journal of Alzheimer s DiseasePeer-reviewed·Jan 1, 2018